With cases reaching  2021-high, Erdogan determined to keep the economy open


Turkey recorded 16, 505 new coronavirus cases on Tuesday, the highest daily rise this year second day in a row, official data showed, as positive/test ratio climbed over 10%.  Medical professional almost unanimously contend that the easing of social restrictions underway, dabbed “controlled normalization” is accentuating the transmission of the virus, with all major variants now amply diagnosed in the population.

Nevertheless, President Tayyip Erdogan said no new restrictions against the pandemic would be imposed for now, stating “we’ll have to see”. Erdogan acknowledged the recent rise in cases over the past two weeks since restrictions were eased in many provinces on March 1, when daily cases were just below 10,000 across Turkey. He said despite a rise in cases in some provinces, hospitalisations, and intensive care unit and intubation levels had not increased.


“We decided to continue the current practice in our cities in today’s meeting and to closely follow the developments,” Erdogan told reporters after a Cabinet meeting.


Turkey eased pandemic measures two weeks ago on a province-by-province basis, and said the measures would be evaluated every two weeks.


WATCH:  Turkey 2021: Infection, oppression and stagnation


Provinces are ranked on a scale of low to very high risk based on average daily cases per 100,000 people. Although average daily cases in some provinces have risen above the cut-off for their current risk group, no changes to the provinces’ status were announced.


“I think that our people were not able to show the necessary attention to abiding by the rules with the first excitement of normalisation,” Erdogan said.



WATCH:  President Erdogan wants to go to the Moon, people want supper


“God willing, by acting much more consciously and carefully from now on, we will overcome this issue all together,” he added.


Turkey, with a population of 83 million, has administered about 11.5 million vaccine doses in a campaign that began in mid-January. More than 7.93 million people have received a first shot and nearly 3.57 million a second dose of the vaccine developed by China’s Sinovac Biotech.



Deliveries of new batches from China are delayed, though Ankara can’t proffer any specific reasons for the delay.  Some analysts suspect attempts by center-right IYIP and small nationalist BBP to declare China employing genocide to Uighurs may have held back the deliveries.  Turkey’s “national vaccine” will not be ready before the end of the year, while the Health Ministry’s official plan is to inoculate 50 million people, not sufficient to reach herd immunity by October.



Source:  Reuters, ParaAnaliz, Haberdar.com


Follow our  English language YouTube videos  @ REAL TURKEY:   https://www.youtube.com/channel/UCKpFJB4GFiNkhmpVZQ_d9Rg


And content at Twitter: @AtillaEng

Facebook:  Real Turkey Channel:   https://www.facebook.com/realturkeychannel/




Published By: Atilla Yeşilada

GlobalSource Partners’ Turkey Country Analyst Atilla Yesilada is the country’s leading political analyst and commentator. He is known throughout the finance and political science world for his thorough and outspoken coverage of Turkey’s political and financial developments. In addition to his extensive writing schedule, he is often called upon to provide his political expertise on major radio and television channels. Based in Istanbul, Atilla is co-founder of the information platform Istanbul Analytics and is one of GlobalSource’s local partners in Turkey. In addition to his consulting work and speaking engagements throughout the US, Europe and the Middle East, he writes regular columns for Turkey’s leading financial websites VATAN and www.paraanaliz.com and has contributed to the financial daily Referans and the liberal daily Radikal.